Navigation Links
Does foreign policy help or hinder global health?
Date:4/20/2010

This week PLoS Medicine launches a series on Global Health Diplomacy with an introductory article outlining the intersection between foreign policy and global health interests, and a case study of Brazil's growing influence in international relations.

In the first article in the series, Harley Feldbaum and Joshua Michaud from the Johns Hopkins School of Advanced International Studies in Washington DC address how the public health community has "seized upon" the concept of health diplomacy to raise the profile of health in the practice of foreign policy, often uncritically. They observe that foreign policy priorities can often determine priority setting and funding for global health, reflected in recent times by the focus of certain governments on the threat of bioterrorism, risks of infectious disease like H1N1 influenza, and operations in Iraq and Afghanistan designed to "win hearts and minds."

Moreover, the authors argue, health interventions are sometimes used to further ulterior foreign policy objectives. For example, "countries are increasingly using health initiatives as a means to improve security, project power and influence, improve their international image, or support other traditional foreign policy objectives." For this reason, the authors conclude, public health advocates must engage with foreign policy interests with caution.

In the second article in the series, Kelley Lee from the London School of Hygiene & Tropical Medicine (LSHTM) and colleagues analyze the growing influence of Brazil in international relations and, in particular, its prominent role in negotiating the Framework Convention for Tobacco Control (FCTC). The authors report that Brazil has achieved this recognition by engaging in "soft power" a diplomatic approach based on persuasion and collaboration, rather than economic influence or political domination. In the FCTC negotiations, Brazil was instrumental by serving as an exemplar for domestic tobacco control, engaging in "coalition politics," and providing leadership throughout the negotiation process. This use of soft power in global tobacco control follows on from Brazil's prominence in the access to medicines debate, focused on upholding the country's constitutional guarantee of access to anti-retr oviral drugs for people living with HIV/AIDS and negotiating firmly to ensure access within World Trade Organization guidelines.

The PLoS Medicine series continues over the coming weeks with additional case studies examining SARS as a watershed for China's engagement in global health diplomacy, and the controversies surrounding avian influenza A (H5N1) and pandemic influenza A (H1N1) in potentially limiting equitable access to influenza vaccine. The PLoS Medicine series concludes on 11 May 2010 with commentary from high-level diplomats providing critical insights into the challenges of engaging in global health diplomacy.


'/>"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
Source:Eurekalert

Related medicine news :

1. Testimony Before the House Committee on Foreign Affairs Regarding the Fiscal Year 2011 Budget Request
2. Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009
3. ACS Webinar features tips for finding and building a career in public policy and chemical industry
4. National Center for Policy Analysis and Salem Radio Network Deliver One Million Emails to Congress to Stop ObamaCare
5. Digital Policy Council Urges Heads of State to Lead and Follow -- with Good Governance on the Net
6. Johns Hopkins Launches “Energy Policy and Climate” Master's Degree
7. Long Island Pediatric Group Announces Policy Changes That Will Help More New Yorkers
8. Michael A. Stephens Appointed Senior Policy Director at Association of Schools of Public Health
9. How can policymakers cope with ambiguity?
10. Health Plan Policy Rescission Won't Go Away, Says NAIRO
11. ACP Advocate blog cited as best health policy/ethics Weblog
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... , ... May 02, 2016 , ... ... website to help consumers better understand life insurance throughout various life stages. , ... an easy-to-use life insurance needs calculator and content specific to the times when ...
(Date:5/2/2016)... ... May 02, 2016 , ... WestHarbor Growth Partners, a growth, ... release of Grow Healthy Vending’s newly revamped brand campaign. Grow Healthy Vending ... vending providers in North America with locations across the United States as well ...
(Date:5/2/2016)... Naperville, Illinois (PRWEB) , ... May 02, 2016 , ... ... our modernized mail back service. MedPro now offers its mail back service for ... this offer; we are now able to provide service to all of the clients ...
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Dr. Rassouli, ... dental health and cognitive decline. According to the research, which was published in the ... degree of cognitive decline, and about 5.4 million Americans have Alzheimer’s disease. The study ...
(Date:5/2/2016)... , ... May 02, 2016 , ... According to an ... one in four girls are sexually abused before the age of 18. Of those ... to tell her story and others. , In her new book, Lyah! Lyah! ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, announced ... 2016 conference, presented by Joseph Gunnar & Co. ... New York . Nadav Kidron , CEO of ... Presentation Details:   PIONEERS 2016, presented ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
Breaking Medicine Technology: